WAI CHUN BIOTEC Delays 2026 Annual Results, Trading Suspended from October 2

Stock News
10/02

WAI CHUN BIOTEC (00660) has announced that, due to the company and its auditor requiring additional time to complete the audit, it will be unable to publish its 2026 annual results on or before September 30, 2026, as required under Listing Rule 13.49(1).

The company is working closely with its auditor, providing all necessary information and documents to complete the audit procedures as soon as possible, but further discussions with the auditor are needed to determine the expected publication date of the annual results, and an announcement will be made in due course.

Under Listing Rule 13.50, if an issuer fails to publish periodic financial information in accordance with the Listing Rules, the Hong Kong Stock Exchange will typically require a suspension of trading in the issuer's securities, and such suspension will generally continue until the issuer publishes an announcement containing the required financial information.

In accordance with the Listing Rules, if the 2026 annual results are not published before September 30, 2026, trading in the company's shares is expected to be suspended on the Stock Exchange, effective from 9:00 a.m. on the next business day following that deadline, which is October 2, 2026.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10